000			01937 a2200577 4500
005			20250518061111.0
264		0	_c20200408
008			202004s 0 0 eng d
022			_a1936-0541
024	7		_a10.1007/s12072-019-09985-w _2doi
040			_aNLM _beng _cNLM
100	1		_aEl-Araby, Hanaa A
245	0	0	_aGeneric sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents. _h[electronic resource]
260			_bHepatology international _cNov 2019
300			_a706-714 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdolescent Health Services
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aBenzimidazoles _xadministration & dosage
650	0	4	_aChild
650	0	4	_aChild Health Services
650	0	4	_aDrug Administration Schedule
650	0	4	_aEgypt
650	0	4	_aFemale
650	0	4	_aFluorenes _xadministration & dosage
650	0	4	_aGenotype
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProspective Studies
650	0	4	_aSofosbuvir
650	0	4	_aTreatment Outcome
650	0	4	_aUridine Monophosphate _xadministration & dosage
700	1		_aBehairy, Behairy E
700	1		_aEl-Guindi, Mohamed A
700	1		_aAdawy, Nermin M
700	1		_aAllam, Alif A
700	1		_aSira, Ahmad M
700	1		_aKhedr, Mohamed A
700	1		_aElhenawy, Ibrahim A
700	1		_aSobhy, Gihan A
700	1		_aBasiouny, Hosam El Din M
700	1		_aSalem, Menan E
700	1		_aAbdel-Aziz, Samira A
700	1		_aFouad, Ola A
700	1		_aAyoub, Bassam A
773	0		_tHepatology international _gvol. 13 _gno. 6 _gp. 706-714
856	4	0	_uhttps://doi.org/10.1007/s12072-019-09985-w _zAvailable from publisher's website
999			_c30106800 _d30106800